The drugs covered under the agreement include: — Poteligeo, for the treatment of mycosis fungoides or Sézary syndrome; — Oxlumo, for the treatment of hyperoxaluria type 1; — Epkinly ...

multi-cohort Phase 2 clinical trial evaluating lacutamab in patients with Sézary syndrome and mycosis fungoides. The Phase 2 KILT (anti-KIR in T Cell Lymphoma) trial, an investigator-sponsored ...

The following is a summary of “ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome,” published in the April 2025 issue of ...

The drugs covered under the agreement include: — Poteligeo, for the treatment of mycosis fungoides or Sézary syndrome; — Oxlumo, for the treatment of hyperoxaluria type 1; — Epkinly, for relapsed or ...

Am J Hematol. 2017;92(10):1085-1102. doi:org/10.1002/ajh.24876 National Library of Medicine. Mycosis fungoides. National Library of Medicine. Sézary syndrome. Lymphoma Research Foundation. Cutaneous B ...

HALIFAX - Nova Scotia still hasn’t signed on to the federal government’s pharmacare plan, and the province’s Opposition New Democrats are wondering why. NDP Leader Claudia Chender said ...